Advertisement
Journal of Oncology Practice  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search or Browse JOP Subscriptions PDA Services E-mail Alerts Customer Service

Journal of Oncology Practice, Vol 5, No 2 (March), 2009: pp. 86-90
© 2009 American Society of Clinical Oncology.
DOI: 10.1200/JOP.0922502

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Business of the Business

Overview of Medicare Parts A-D

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

As Medicare spending continues to climb, policymakers are calling for major reforms to ensure that Medicare beneficiaries continue to have access to care without bankrupting the Medicare Trust Fund (Fig 1). It's hard to know what the future holds for health care and how potential changes to the system would affect cancer care delivery. In the following pages, we'll present a primer on Medicare Parts A-D to provide oncologists context for the substantive Medicare reform debates that are anticipated to begin during the coming months.


Figure Removed (Available Only in the Full Text)
View larger version (24K):



 
Figure 1. These projections are based on the trustees' intermediate set of assumptions. Source: 2008 . . . [Click for More]

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Oncol PractHome page
B. McAneny, T. Marsland, and K. King
News and Notes From the 2009 Carrier Advisory Committee Meeting: Medical Necessity, Off-Label Chemotherapy, and More
J. Oncol. Pract, November 1, 2009; 5(6): 301 - 304.
[Full Text] [PDF]


Home page
J Oncol PractHome page
J. V. Cox
Medicare's Seasons
J. Oncol. Pract, March 1, 2009; 5(2): 49 - 49.
[Full Text] [PDF]



About
JOP
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1935-469X. Print ISSN: 1554-7477
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JOP Online